Lupin's Soon-To-Be CEO Eyes Market Expansions To China, Latam, Russia
This article was originally published in PharmAsia News
Lupin is looking to expand its business beyond the dominance of the India, Japan and the U.S. markets to China, Latin America and Russia, according to Vinita Gupta, set to take over as CEO in September.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.